Subdissociative-dose ketamine for sickle cell vaso-occlusive crisis: a narrative review for the emergency physician
Mohammad H. Bawany, Sergey M. Motov
Clin Exp Emerg Med. 2022;9(3):169-175.   Published online 2022 Sep 30     DOI: https://doi.org/10.15441/ceem.22.326
Citations to this article as recorded by Crossref logo
Is the early use of ketamine effective as an opioid sparing adjunct for treating pain in sickle cell disease patients?
Vineetha Reddy Nallagatla, Natasha M Archer
Expert Review of Hematology.2025; 18(6): 435.     CrossRef
Emergency department pain management in special populations
Katherine Vlasica, Amanda Hall, Mohammad Anzal Rehman, George Notas, Christina Shenvi, Sergey Motov
Turkish Journal of Emergency Medicine.2025; 25(3): 159.     CrossRef